Bluesight has acquired healthcare compliance analytics platform provider Protenus to enhance its drug diversion platform and introduce essential patient privacy monitoring features.
This helps improve the protection of healthcare organisations and the communities served by them.
Go deeper with GlobalData
The acquisition will see the amalgamation of Bluesight’s intelligence and Protenus’ specialisation in compliance and risk management, featuring a combined platform.
Bluesight co-founder and CEO Kevin MacDonald said: “Protenus is at the forefront of healthcare compliance AI & analytics, addressing the critical need for compliance technology that helps healthcare organisations meet and exceed the highest quality of care and safety standards.
“We have long admired their products, expertise and team, and this acquisition is a transformational step in Bluesight’s journey to expand our compliance capabilities. By combining our strengths, we will be able to offer a truly comprehensive solution that addresses some of the most pressing healthcare challenges today and deliver even greater value to our customers.”
Protenus provides scalable risk-reduction solutions to healthcare organisations using artificial intelligence. This approach helps the organisations garner safe and quality patient results.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataSince its inception in 2014, the company is supporting healthcare organisations in the US to navigate risks pertaining to operations.
Protenus co-founder and CEO Nick Culbertson said: “We are thrilled to join the Bluesight platform, which will help accelerate our mission of empowering healthcare organisations with the necessary tools to protect their patients and safeguard their own reputations.
“Partnering with Bluesight will enhance our capacity to innovate and address our customers’ evolving needs, and allow us to further capitalise on the growing demand for our compliance capabilities. Together, we will create a platform that not only mitigates risks but also establishes new standards for excellence in healthcare compliance and beyond.”
